scutellarin has been researched along with Cardiovascular Stroke in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, ZQ; Huang, JW; Li, HL; Li, L; Li, T; Zheng, J; Zhou, Y | 1 |
| Ji, SY; Jing, R; Liu, SZ; Lou, WJ; Wang, J | 1 |
| Lin, LL; Liu, AJ; Liu, JG; Qin, LP; Su, DF; Yu, XH | 1 |
| Ma, Q; Wang, L | 1 |
| Feng, S; Liu, X; Lu, Y; Pan, Z; Sun, X; Wang, B; Wang, J; Yang, B; Zhang, X; Zhao, W | 1 |
1 review(s) available for scutellarin and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical benefits and pharmacology of scutellarin: A comprehensive review.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Biological Availability; Glucuronates; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Stroke | 2018 |
4 other study(ies) available for scutellarin and Cardiovascular Stroke
| Article | Year |
|---|---|
Breviscapine Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Rats After Coronary Microembolization by Activating the PI3K/Akt/GSK-3β Signaling Pathway.
Topics: Administration, Oral; Animals; Apoptosis; Coronary Vessels; Dose-Response Relationship, Drug; Flavonoids; Glycogen Synthase Kinase 3 beta; Inflammation; Male; Molecular Structure; Myocardial Infarction; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Structure-Activity Relationship | 2021 |
Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Topics: Animals; Apoptosis; Cardiotonic Agents; Caspase 3; Cell Line; Flavonoids; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Troponin I | 2015 |
Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats.
Topics: Animals; Apigenin; Apoptosis; Brain Ischemia; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Combinations; Flavonoids; Glucuronates; Infarction, Middle Cerebral Artery; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Toxicity Tests, Acute | 2007 |
Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.
Topics: Animals; Apigenin; Collagen; Cytokines; Drugs, Chinese Herbal; Echocardiography; Erigeron; Fibrosis; Glucuronates; Heart Failure; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Rats; Rats, Wistar; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |